Broadly speaking, Geneway is looking at two areas for risk of cancer: lack of detoxification abilities and build-up of ‘bad’ estrogens.
If the genes that must tell your body to detoxify cannot do so, it increases the risk of cancer if you are exposed to that particular toxin. For example, if a gene called NQO1 does not work, it means it cannot detoxify benzene-products, including the preservatives Benzoic Acid. If someone with a dysfunctional NQO1 gene consumes products with Benzoic Acid, it increases the risk for especially colon and bladder cancer.
There are several other examples as well since there are so many different toxins – the different toxins are often metabolized by different genes and are associated with different types of cancer – but they are all falling under the umbrella of poor detoxification.
The second cancer risk is about how your body can get rid of bad estrogens. Bad estrogen build-up can increase the risk of breast and ovarian cancers.
The value of this testing is to identify the risks and then implement changes to reduce the risks and exposures and increase or decrease certain nutrients – thus these tests are not diagnostic.
The risks for cancer are part of the GeneWell test, so that will be the test to select.
